Overview
Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors
Status:
Recruiting
Recruiting
Trial end date:
2026-12-01
2026-12-01
Target enrollment:
Participant gender: